Match!
Sara Monti
University of Pavia
Physical therapyGiant cell arteritisDiseaseDiabetes mellitusMedicine
122Publications
23H-index
3,156Citations
What is this?
Publications 122
Newest
We appreciated the comment from Schulze-Koops et al 1 in response to our paper on the clinical course and outcome of COVID-19 in a cohort of patients treated with biological and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs).2 The authors stated that the message conveyed by our report or other similar observational data or clinical studies is potentially harmful for patients with rheumatic diseases who might think they are protected against complications of COVID-19 by the...
Source
#1Paolo DelvinoH-Index: 2
#2Alessandro BigliaH-Index: 1
Last. Lorenzo CavagnaH-Index: 25
view all 8 authors...
Source
#1Alessandro Biglia (UNIPV: University of Pavia)H-Index: 1
#2Valentina Morandi (UNIPV: University of Pavia)H-Index: 4
Last. Carlomaurizio Montecucco (UNIPV: University of Pavia)H-Index: 48
view all 6 authors...
Abstract Cobalt-containing hip prosthesis may cause systemic toxicity due to the release of cobalt from metal-on-metal (MoM) joint arthroplasty into the bloodstream. High cobalt blood levels can lead to a variety of clinical manifestations, mimicking other disorders, especially autoimmune, hematologic, and infectious diseases. Our purpose is to describe a clinical case of cobalt hip prosthesis intoxication mimicking an autoimmune disease, with systemic inflammation signs, arthro-myalgias unrelat...
Source
#2Sara MontiH-Index: 23
Last. Carlomaurizio MontecuccoH-Index: 48
view all 6 authors...
OBJECTIVES: To describe the incidence and severity of coronavirus disease 2019 (COVID-19) in rheumatic patients treated with targeted synthetic or biological anti-rheumatic drugs (ts/bDMARDs) compared with the general population living in the same Italian region. METHODS: Patients followed at two referral rheumatology centres in Lombardy from 25th February to 10th April 2020 were invited to participate in a survey to detect patients with confirmed COVID-19, close contacts with known COVID-19 cas...
1 CitationsSource
We appreciate the comment from Dr Kobak1 to our previously published report on the clinical course and outcome of COVID-19 in a cohort of patients treated with biologic and targeted synthetic disease modifying antirheumatic drugs.2 The author described the case of a patient with familial Mediterranean fever treated with colchicine who experienced a mild course of …
Source
#1Paolo Delvino (UNIPV: University of Pavia)H-Index: 2
#2Francesco Sardanelli (UniGe: University of Genoa)H-Index: 42
Last. Benjamin Terrier (Paris V: Paris Descartes University)H-Index: 38
view all 9 authors...
Background: Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) require glucocorticoids (GCs) and immunosuppressants (IS) to induce and maintain remission. At the era of highly active drugs and treat-to-target strategies, defining the goal to achieve in terms of remission could be beneficial for the long-term management. Objectives: To assess the impact of prolonged remission or low disease activity state (LDAS) in GPA and MPA patients and its relationship with damage accru...
Source
#1Paolo Delvino (UNIPV: University of Pavia)H-Index: 2
#2Sara Monti (UNIPV: University of Pavia)H-Index: 23
Last. Carlomaurizio Montecucco (UNIPV: University of Pavia)H-Index: 48
view all 7 authors...
Background: Giant Cell Arteritis (GCA) is the most common form of primary systemic vasculitis, mainly affecting adults over 50 years old. Permanent visual loss (PVL) is one of the most feared complications, occurring in about 20% of cases, typically prior to initiation of high-dose glucocorticoid (GC) therapy. Color-duplex sonography (CDS) of temporal arteries (TAs) and large vessels (LVs) is recognized as a first-line diagnostic tool for patients with suspected GCA. A fast track approach (FTA),...
Source
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 has significantly challenged hospitals surge capacity and the perceived priorities for medical investigations performed to diagnose or monitor other diseases.1 2 Recent studies have reported increased mortality in out-of-hospital acute coronary syndromes, not fully explained by COVID-19 cases alone, and potentially related to the patients’ reluctance to seek medical care out of fear of the infection threat.3 4 ...
1 CitationsSource
#1Sara Monti (UNIPV: University of Pavia)H-Index: 23
#2Anthea Craven (University of Oxford)H-Index: 11
Last. Raashid Luqmani (University of Oxford)H-Index: 54
view all 8 authors...
OBJECTIVES: ANCA-associated vasculitis (AAV) can affect all age groups. We aimed to show that differences in disease presentation and 6 month outcome between younger- and older-onset patients are still incompletely understood. METHODS: We included patients enrolled in the Diagnostic and Classification Criteria for Primary Systemic Vasculitis (DCVAS) study between October 2010 and January 2017 with a diagnosis of AAV. We divided the population according to age at diagnosis: 65 years of age displa...
Source
We thank Dr Moiseev et al 1 for their comment on our previous paper on the clinical course of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) disease 2019 (COVID-19) in patients treated with biologic and targeted synthetic disease-modifying anti-rheumatic drugs.2 The authors assessed the outcome of patients with inflammatory rheumatic diseases among patients admitted to the intensive care unit (ICU) and reported findings in line with our cohort of outpatients.2 Admission to the ICU ...
Source
12345678910